TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
INCR

InterCure Ltd.

Healthcare · Drug Manufacturers - Specialty & Generic

5.20$ +2.8% vs. previous close Closing price · As of: Sep 29, 2026

Statements

Balance Sheet

InterCure Ltd. (INCR) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Total Assets" came in at 691 million ILS. Tick rows to compare them in a chart.

All figures in millions of ILS.

Tick rows to compare them in a chart (up to 4)

Balance Sheet INCR
Line item 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
– 2.9 15 6.2 2.6 13 28 24 36 282 326 686 958 787 763 691
– 2.6 14 5.7 2.6 3.9 3.3 2.5 5.0 42 77 336 527 419 392 317
– 1.2 3.6 0.8 0.2 2.7 2.8 2.1 3.4 27 38 196 233 101 78 46
– 1.2 13 3.9 1.9 3.8 3.3 2.4 3.7 28 38 197 233 101 79 47
– 0.9 0.3 0.4 0.3 0.0 0.0 0.0 1.3 6.6 15 38 50 61 180 154
– 0.3 0.9 1.1 0.5 0.0 0.0 0.0 -1.5 5.8 22 68 146 106 125 108
– – – – – – – 0.0 0.1 32 53 87 – – – –
– – – – – – – – – 168 190 258 284 221 225 219
– – 0.5 0.4 – – – – – – – – – – – –
– 55 4.7 2.2 1.9 0.7 3.7 3.3 16 26 34 227 437 330 365 294
– 54 4.6 2.2 1.9 0.7 3.7 3.3 16 23 30 194 313 226 227 214
– 40 1.3 0.7 0.5 0.2 2.4 2.9 13 14 2.6 76 132 93 74 104
– 3.0 2.2 1.0 0.7 0.2 0.4 0.3 0.2 4.9 19 64 126 78 78 68
– – – – – – – – – 0.4 0.6 12 100 82 114 59
– -52 9.8 3.9 0.7 12 24 21 20 256 275 448 501 455 397 397
– -167 -121 -119 -137 -139 -137 -129 -148 -151 -191 -186 -142 -204 -278 -315
0.1 0.1 0.1 0.3 0.3 1.8 2.6 3.4 4.1 4.7 5.1 8.2 9.1 9.1 9.6 11

Data as of: September 29, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?